A.R.T. Advisors’s Aravive, Inc. Common Stock ARAV Stock Holding History

A.R.T. Advisors’s Portfolio ARAV Stock Details ARAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-6,473	Closed	-$54K	–	1747
2018 Q3	$54K	Buy	+6,473	New	+$68.2K	﹤0.01%	1315
2018 Q2	–	Sell	-14,887	Closed	-$147K	–	1832
2018 Q1	$147K	Buy	+14,887	New	+$167K	0.01%	1319
2017 Q4	–	Sell	-4,753	Closed	-$69K	–	1740
2017 Q3	$69K	Buy	+4,753	New	+$479K	﹤0.01%	1237
2017 Q2	–	Sell	-4,520	Closed	-$579K	–	1798
2017 Q1	$579K	Buy	4,520 +237	+6%	+$25K	0.03%	762
2016 Q4	$382K	Buy	+4,283	New	+$325K	0.02%	855
2016 Q3	–	Sell	-2,925	Closed	-$194K	–	1247
2016 Q2	$194K	Buy	2,925 +1,127	+63%	+$64.1K	0.01%	1115
2016 Q1	$86K	Sell	1,798 -766	-30%	-$40.6K	﹤0.01%	1263
2015 Q4	$190K	Buy	+2,564	New	+$172K	0.01%	1239
2015 Q3	–	Sell	-2,410	Closed	-$220K	–	1662
2015 Q2	$220K	Sell	2,410 -2,070	-46%	-$210K	0.01%	1270
2015 Q1	$493K	Buy	+4,480	New	+$526K	0.02%	923

Other funds holding ARAV

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BOTOTLSJU

Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NTC

NF Trinity Capital Central, Hong Kong $626M AUM 3.16% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

A.R.T. Advisors's ARAV Position: Q4 2018 in Review

A.R.T. Advisors sold out of Aravive, Inc. Common Stock (ARAV) in Q4 2018, closing a stake of 6,473 shares — an estimated $54K sold.

A.R.T. Advisors first reported a position in ARAV in Q1 2015 and held it in 10 quarters. The position peaked at $579K in Q1 2017. 38 funds tracked by Wall St. Rank hold ARAV as of Q4 2018.

A.R.T. Advisors reported no remaining Aravive, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
A.R.T. Advisors sold 6,473 Aravive, Inc. Common Stock shares in Q4 2018, an estimated $54K.
A.R.T. Advisors first reported a position in Aravive, Inc. Common Stock in Q1 2015 and held it in 10 quarters.
A.R.T. Advisors's Aravive, Inc. Common Stock position peaked at $579K in Q1 2017.
38 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q4 2018.

Based on A.R.T. Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.